verapamil has been researched along with Anasarca in 22 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We studied the effect of verapamil on intestinal ischemia and reperfusion (I/R) injury." | 7.70 | Beneficial effects of verapamil on intestinal ischemia and reperfusion injury: pretreatment versus postischemic treatment. ( Fujii, Y; Kataoka, M; Kato, T; Kimura, M; Kuwabara, Y; Narita, K; Okahira, T; Sato, A, 1998) |
| "The authors examined the efficacy and safety of the combination of verapamil and nifedipine in the control of hypertension." | 7.69 | Verapamil and nifedipine in combination for the treatment of hypertension. ( Bottini, PB; Carr, AA; Kaesemeyer, WH; Prisant, LM, 1994) |
| " The effects of the calcium channel blockers, verapamil and nifedipine on myocardial ischaemia and oedema evoked by endothelin-1 (ET-1) or IRL 1620, an ETB receptor-selective agonist were studied in anaesthetized and conscious rats." | 7.69 | Effects of calcium antagonists on endothelin-1-induced myocardial ischaemia and oedema in the rat. ( Filep, JG; Földes-Filep, E; Fournier, A; Skrobik, Y, 1996) |
| "When verapamil was combined with diclofenac, in vitro, the inhibitory effect on PMA or OPZ-induced CL response was synergistic." | 5.28 | Verapamil enhances the inhibitory effect of diclofenac on the chemiluminescence of human polymorphonuclear leukocytes and carrageenan-induced rat's paw oedema. ( al-Tuwaijri, AS; Mustafa, AA, 1992) |
| "002; multivariate analysis of variance), with 7 significant univariate treatment effects, all favoring COER-verapamil, being noted-pedal edema, polyuria, rapid heart beat or palpitations, hives, muscle cramps, abdominal cramps, and headaches." | 5.09 | Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life. ( Anderson, RB; Hollenberg, NK; Williams, GH, 1999) |
| " In this study, taking advantage of the transparency of larval zebrafish, Danio rerio, we assessed cardiovascular toxicity of seven known human cardiotoxic drugs (aspirin, clomipramine hydrochloride, cyclophosphamide, nimodipine, quinidine, terfenadine and verapamil hydrochloride) and two non-cardiovascular toxicity drugs (gentamicin sulphate and tetracycline hydrochloride) in zebrafish using six specific phenotypic endpoints: heart rate, heart rhythm, pericardial edema, circulation, hemorrhage and thrombosis." | 3.80 | Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish. ( Dong, QX; Gao, JM; He, JH; Huang, CJ; Li, CQ; Xu, YQ; Xuan, YX; Yu, HP; Zhu, JJ, 2014) |
| "We studied the effect of verapamil on intestinal ischemia and reperfusion (I/R) injury." | 3.70 | Beneficial effects of verapamil on intestinal ischemia and reperfusion injury: pretreatment versus postischemic treatment. ( Fujii, Y; Kataoka, M; Kato, T; Kimura, M; Kuwabara, Y; Narita, K; Okahira, T; Sato, A, 1998) |
| "The authors examined the efficacy and safety of the combination of verapamil and nifedipine in the control of hypertension." | 3.69 | Verapamil and nifedipine in combination for the treatment of hypertension. ( Bottini, PB; Carr, AA; Kaesemeyer, WH; Prisant, LM, 1994) |
| " The effects of the calcium channel blockers, verapamil and nifedipine on myocardial ischaemia and oedema evoked by endothelin-1 (ET-1) or IRL 1620, an ETB receptor-selective agonist were studied in anaesthetized and conscious rats." | 3.69 | Effects of calcium antagonists on endothelin-1-induced myocardial ischaemia and oedema in the rat. ( Filep, JG; Földes-Filep, E; Fournier, A; Skrobik, Y, 1996) |
| " The 5-HT2 receptor-antagonistic properties of AHR-16303B were demonstrated by inhibition of (a) [3H]ketanserin binding to rat cerebral cortical membranes (IC50 = 165 nM); (b) 5-hydroxytryptamine (5-HT)-induced foot edema in rats (minimum effective dose, (MED) = 0." | 3.68 | AHR-16303B, a novel antagonist of 5-HT2 receptors and voltage-sensitive calcium channels. ( Appell, KC; Barrett, RJ; Kilpatrick, BF; Nolan, JC; Proakis, AG; Walsh, DA, 1991) |
| "Carrageenin oedema is enhanced by the simultaneous injection in the rat paw of platelet activating factor (PAF)." | 1.29 | Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents. ( Autore, G; Capasso, F; Di Carlo, G; Di Urno, MV; Izzo, AA; Mascolo, N, 1994) |
| "When verapamil was combined with diclofenac, in vitro, the inhibitory effect on PMA or OPZ-induced CL response was synergistic." | 1.28 | Verapamil enhances the inhibitory effect of diclofenac on the chemiluminescence of human polymorphonuclear leukocytes and carrageenan-induced rat's paw oedema. ( al-Tuwaijri, AS; Mustafa, AA, 1992) |
| "A case of severe nonimmune hydrops fetalis caused by supraventricular tachycardia is presented." | 1.27 | Insufficient transplacental digoxin transfer in severe hydrops fetalis. ( Granat, M; Younis, JS, 1987) |
| "If oedema is associated with fetal cardiac arrhythmic conditions it can in certain cases be treated and cured in utero." | 1.27 | [Prenatal echographic diagnosis of fetoplacental anasarca]. ( de Grandi, P; Nguyen The, H; Stadlin, M, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (36.36) | 18.7374 |
| 1990's | 10 (45.45) | 18.2507 |
| 2000's | 1 (4.55) | 29.6817 |
| 2010's | 3 (13.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, H | 2 |
| Saeed, M | 2 |
| Mehmood, MH | 2 |
| Rehman, NU | 2 |
| Muhammad, N | 2 |
| Haq, IU | 2 |
| Ashraf, N | 1 |
| El-Tahir, KE | 1 |
| Gilani, AH | 2 |
| Abbas, M | 1 |
| Zhu, JJ | 1 |
| Xu, YQ | 1 |
| He, JH | 1 |
| Yu, HP | 1 |
| Huang, CJ | 1 |
| Gao, JM | 1 |
| Dong, QX | 1 |
| Xuan, YX | 1 |
| Li, CQ | 1 |
| Tobin, J | 1 |
| Flitman, S | 1 |
| Goldenberg, MM | 1 |
| Meurer, RD | 1 |
| Sobotka, MA | 1 |
| Exalto, N | 1 |
| Dijkhuizen, GH | 1 |
| van der Vorm, DH | 1 |
| Izzo, AA | 1 |
| Mascolo, N | 1 |
| Di Urno, MV | 1 |
| Autore, G | 1 |
| Di Carlo, G | 1 |
| Capasso, F | 1 |
| Nagahisa, A | 1 |
| Asai, R | 1 |
| Kanai, Y | 1 |
| Murase, A | 1 |
| Tsuchiya-Nakagaki, M | 1 |
| Nakagaki, T | 1 |
| Shieh, TC | 1 |
| Taniguchi, K | 1 |
| Kaesemeyer, WH | 1 |
| Carr, AA | 1 |
| Bottini, PB | 1 |
| Prisant, LM | 1 |
| Battalora, MS | 1 |
| Johnston, DA | 1 |
| DiGiovanni, J | 1 |
| Filep, JG | 1 |
| Skrobik, Y | 1 |
| Fournier, A | 1 |
| Földes-Filep, E | 1 |
| Taherzadeh, M | 1 |
| Warren, JB | 1 |
| Kimura, M | 1 |
| Kataoka, M | 1 |
| Kuwabara, Y | 1 |
| Sato, A | 1 |
| Kato, T | 1 |
| Narita, K | 1 |
| Okahira, T | 1 |
| Fujii, Y | 1 |
| Anderson, RB | 1 |
| Hollenberg, NK | 1 |
| Williams, GH | 1 |
| al-Tuwaijri, AS | 1 |
| Mustafa, AA | 1 |
| Barrett, RJ | 1 |
| Appell, KC | 1 |
| Kilpatrick, BF | 1 |
| Proakis, AG | 1 |
| Nolan, JC | 1 |
| Walsh, DA | 1 |
| Srivastava, VK | 1 |
| Saxena, KK | 1 |
| Gupta, B | 1 |
| Maxwell, DJ | 1 |
| Crawford, DC | 1 |
| Curry, PV | 1 |
| Tynan, MJ | 1 |
| Allan, LD | 1 |
| Younis, JS | 1 |
| Granat, M | 1 |
| Castro, R | 1 |
| Perera, C | 1 |
| Doménech, E | 1 |
| Méndez, A | 1 |
| Ormazábal, C | 1 |
| Nguyen The, H | 1 |
| Stadlin, M | 1 |
| de Grandi, P | 1 |
| Kaltenbach, M | 1 |
| Hopf, R | 1 |
1 trial available for verapamil and Anasarca
| Article | Year |
|---|---|
Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Calcium Channel Blockers; Constipation; Dou | 1999 |
21 other studies available for verapamil and Anasarca
| Article | Year |
|---|---|
Studies on tracheorelaxant and anti-inflammatory activities of rhizomes of Polygonatum verticillatum.
Topics: Animals; Anti-Inflammatory Agents; Calcium Channel Blockers; Carbachol; Carrageenan; Edema; Female; | 2013 |
Bronchodilator activity of aerial parts of Polygonatum verticillatum augmented by anti-inflammatory activity: attenuation of Ca²⁺ channels and lipoxygenase.
Topics: Animals; Anti-Inflammatory Agents; Bronchodilator Agents; Calcium Channel Blockers; Carbachol; Carra | 2013 |
Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish.
Topics: Abnormalities, Drug-Induced; Animals; Aspirin; Cardiotoxins; Clomipramine; Cyclophosphamide; Disease | 2014 |
Cluster-like headaches associated with internal carotid artery dissection responsive to verapamil.
Topics: Anticoagulants; Blepharoptosis; Carotid Artery, Internal, Dissection; Cluster Headache; Diagnosis, D | 2008 |
A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw edema in the rat.
Topics: Animals; Carrageenan; Dexamethasone; Dose-Response Relationship, Drug; Edema; Hindlimb; Indomethacin | 1984 |
[Fetal hydrops as a result of supraventricular tachycardia].
Topics: Adult; Cesarean Section; Digoxin; Edema; Female; Fetal Diseases; Humans; Infant, Newborn; Male; Preg | 1983 |
Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents.
Topics: Animals; Bradykinin; Carrageenan; Cellulose; Dextrans; Dinoprostone; Diterpenes; Drug Synergism; Ede | 1994 |
Non-specific activity of (+/-)CP-96,345 in models of pain and inflammation.
Topics: Animals; Biphenyl Compounds; Carrageenan; Dose-Response Relationship, Drug; Edema; Hyperalgesia; Hyp | 1993 |
Verapamil and nifedipine in combination for the treatment of hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Drug Therapy, Combination; Edema; Female | 1994 |
The effects of calcium antagonists on anthrone skin tumor promotion and promoter-related effects in SENCAR mice.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anthracenes; Calcium; Calcium Channel Blockers; Carcinoge | 1995 |
Effects of calcium antagonists on endothelin-1-induced myocardial ischaemia and oedema in the rat.
Topics: Albumins; Animals; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Edema | 1996 |
Comparison of diltiazem and verapamil on rat microvascular permeability.
Topics: Animals; Capillary Leak Syndrome; Capillary Permeability; Diltiazem; Edema; Evans Blue; Injections, | 1997 |
Beneficial effects of verapamil on intestinal ischemia and reperfusion injury: pretreatment versus postischemic treatment.
Topics: Animals; Edema; Intestinal Diseases; Intestines; Ischemia; Magnetic Resonance Spectroscopy; Male; Ra | 1998 |
Verapamil enhances the inhibitory effect of diclofenac on the chemiluminescence of human polymorphonuclear leukocytes and carrageenan-induced rat's paw oedema.
Topics: Animals; Cell Survival; Diclofenac; Drug Synergism; Edema; Luminescent Measurements; Male; Neutrophi | 1992 |
AHR-16303B, a novel antagonist of 5-HT2 receptors and voltage-sensitive calcium channels.
Topics: Animals; Atrial Function; Blood Pressure; Calcium; Calcium Channel Blockers; Calcium Channels; Calci | 1991 |
Calcium channel blockers in acute inflammation.
Topics: Animals; Carrageenan; Edema; Female; Foot; Histamine; Hyaluronoglucosaminidase; Inflammation; Male; | 1988 |
Obstetric importance, diagnosis, and management of fetal tachycardias.
Topics: Delivery, Obstetric; Digoxin; Drug Therapy, Combination; Edema; Female; Fetal Diseases; Heart Failur | 1988 |
Insufficient transplacental digoxin transfer in severe hydrops fetalis.
Topics: Adult; Digoxin; Edema; Female; Fetal Diseases; Humans; Maternal-Fetal Exchange; Pregnancy; Propranol | 1987 |
[Hydrops fetalis caused by supraventricular tachycardia: effects of the administration of verapamil].
Topics: Edema; Female; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Tachycardia, Supra | 1986 |
[Prenatal echographic diagnosis of fetoplacental anasarca].
Topics: Adult; Digoxin; Edema; Female; Fetal Diseases; Humans; Pregnancy; Tachycardia; Ultrasonography; Vera | 1985 |
Treatment of hypertrophic cardiomyopathy: relation to pathological mechanisms.
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Cardiac Catheterization; Cardio | 1985 |